期刊文献+

原发性高血压早期肾损害检测血清γ-痕迹蛋白、尿NAG与尿微量白蛋白的临床意义 被引量:2

The Clinical Significance of Serum γ-trace Protein、Urine NAG and Microalbuminuria Tested in Primary Hypertension with Early Renal Damage
下载PDF
导出
摘要 目的:探讨血清γ-痕迹蛋白、尿N-乙酰-B-D-氨基葡萄糖苷酶(NAG)与尿微量白蛋白检测对原发性高血压早期肾损害的临床意义。方法:将86例高血压病患者按有无肾脏损害分为两组,原发性高血压肾损害者48例,单纯性高血压患者38例,同时选择54例健康体检人群作为正常对照组。分别测定血清γ-痕迹蛋白、尿NAG、尿微量白蛋白并对结果进行比较分析。结果:单纯性高血压组以上检测项目结果与正常对照组比较差异无显著性(P>0.05);高血压肾损害组各检测结果与对照组比较差异有显著性(P<0.01)。结论:血清γ-痕迹蛋白、尿NAG与尿微量白蛋白联合检测对原发性高血压早期肾损害的诊断有重要意义。 Objective: To investigate clinical significance of γ-trace protein in serum, urine NAG and mALB in primary hypertension with early renal damage. Methods: 86 patients with primary hypertension were divided into two groups according to whether the kidney was damaged. 48 cases were hypertensive nephropathy, 38 cases were simple hypertension,while 54 healthy people worked as control group. The concentrations of serum γ-trace protein, urinary NAG ,mALB were tested, and the results were compared. Results:There was no significant difference in simple hypertension results for all tested items compared with that of control group, but significant with that of hypertensive renal injury group. Conclusion:The joint detection of γ-trace protein in serum,urine NAG and urinary albumin is important for early diagnosis of essential hypertension which results in renal damage.
出处 《河北北方学院学报(医学版)》 2010年第4期6-8,共3页 Journal of Hebei North University:Medical Edition
关键词 高血压 肾病 Γ-痕迹蛋白 尿NAG 尿微量白蛋白 Hypertension, Nephrosis, y-trace protein, Urinary NAG, Urinary albumin
  • 相关文献

参考文献8

二级参考文献31

  • 1[1]Poteryaeva ON, Falameeva OV, Zhanaeva SY, et al. Role of cystatin C and cysteine proteinases in the development of mouse LS-lymphosaroma[J]. Bull-Exp-Biol-Med,2001,132(1 ):675-7.
  • 2[2]Kazama J J, Kutsuwada K, Ataka K. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases[J]. Nephron,2002,91 ( 1 ): 13-20.
  • 3[3]Wu XC, Yi ZW, He X J, et al. Pathological quantitaniue analysis of kidney in purpura nephritis of children[J]. Hu Nan Yi Ke Da Xue Xue Bao, 2000,25(4):403-405. Chinese.
  • 4[4]Mezzano SA, Drougett MA, Burgos ME, et al. Overexpression of chemokines, fibrogenic, cytokines, and myofibroblasts in human mebmbranous nephropathy[J].Kidney Int,2000,57:147-158.
  • 5[5]Tang X, Yuan FH. Relationship between expression of tissre inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 and renal fibrosis[J]. Zhong Guo Xian Dai Yi Xue Za Zhi, 2002,12(2):13-15. Chinese.
  • 6[6]Lukasiuk K, Pirttila TJ, Pitkanen A. Upregulation of cystatin C expression in the rat hippocampus during epileptogenesis in the amygdala stimulation moldel of temporal lobe epilepsy[J]. Epilepsia,2002,43 Suppl (5):137-45.
  • 7[7]Shimizu TA, Kobata M, Io H, et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine [J].Nephron,2002,92(1 ):224-6.
  • 8[8]Takeuchi M, Fukuda Y, Nakano I, et al. Elevation of serum cystatin C concentrations in patients with chronic liver disease[J].Eur J Gastroenterol Hepatol,2001,13(8):951-5.
  • 9[1]Philipou G,Philips PJ.Variability of urinary albumin excretion in patients with microalbuminuria[J].Diabetes Care,1994,17:425-427.
  • 10[2]International Diabetes Federation:The IDF consensus worldwide definition of the metabolic syndrome.Available at:www.idf.org/ webdata/docs/ Metabolic-syndrome-definition.pdf.Accessed April 18,2005.

共引文献181

同被引文献39

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部